Page last updated: 2024-08-25

dicolinium iodide and Cognition Disorders

dicolinium iodide has been researched along with Cognition Disorders in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Persiyantseva, NA; Pinelis, VG; Pomytkin, IA; Proshin, AT; Semenova, NA; Senilova, YE; Sherstnev, VV; Storozheva, ZI; Storozhevykh, TP; Zakharova, EI	1

Other Studies

1 other study(ies) available for dicolinium iodide and Cognition Disorders

Article	Year
Dicholine salt of succinic acid, a neuronal insulin sensitizer, ameliorates cognitive deficits in rodent models of normal aging, chronic cerebral hypoperfusion, and beta-amyloid peptide-(25-35)-induced amnesia. BMC pharmacology, 2008, Jan-23, Volume: 8 Topics: Aging; Amnesia; Amyloid beta-Peptides; Animals; Cerebrovascular Circulation; Choline; Cognition Disorders; Insulin; Mice; Mice, Inbred C57BL; Models, Animal; Neurons; Peptide Fragments; Phosphorylation; Pipecolic Acids; Receptor, Insulin; Succinic Acid	2008

Article

Year

Dicholine salt of succinic acid, a neuronal insulin sensitizer, ameliorates cognitive deficits in rodent models of normal aging, chronic cerebral hypoperfusion, and beta-amyloid peptide-(25-35)-induced amnesia.

BMC pharmacology, 2008, Jan-23, Volume: 8

Topics: Aging; Amnesia; Amyloid beta-Peptides; Animals; Cerebrovascular Circulation; Choline; Cognition Disorders; Insulin; Mice; Mice, Inbred C57BL; Models, Animal; Neurons; Peptide Fragments; Phosphorylation; Pipecolic Acids; Receptor, Insulin; Succinic Acid

2008